Search hospitals > Illinois > Chicago
Rush University Medical Center
Claim this profileChicago, Illinois 60612
Global Leader in Parotid Gland Cancer
Global Leader in Post-Implantation Syndrome
Conducts research for Lymphoma
Conducts research for Breast Cancer
Conducts research for Parkinson's Disease
1654 reported clinical trials
119 medical researchers
Summary
Rush University Medical Center is a medical facility located in Chicago, Illinois. This center is recognized for care of Parotid Gland Cancer, Post-Implantation Syndrome, Lymphoma, Breast Cancer, Parkinson's Disease and other specialties. Rush University Medical Center is involved with conducting 1,654 clinical trials across 1,570 conditions. There are 119 research doctors associated with this hospital, such as Alan Tan, Dian Wang, MD, PhD, Timothy M Kuzel, MD, and James Moy, MD.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage I
2Post-Implantation Syndrome
Global LeaderFMR1 positive
UBE3A positive
MECP2 positive
Top PIs
Alan TanRush University Medical Center5 years of reported clinical research
Studies Parotid Gland Cancer
Studies Kidney Cancer
15 reported clinical trials
26 drugs studied
Dian Wang, MD, PhDRush University Medical Center8 years of reported clinical research
Studies Prostatic Neoplasm
Studies Prostate Cancer
14 reported clinical trials
39 drugs studied
Timothy M Kuzel, MDRush University Medical Center8 years of reported clinical research
Studies Melanoma
Studies Skin Cancer
10 reported clinical trials
35 drugs studied
James Moy, MDRush University Medical Center4 years of reported clinical research
Studies Coronavirus
Studies COVID-19
10 reported clinical trials
17 drugs studied
Clinical Trials running at Rush University Medical Center
Breast Cancer
Lung Cancer
Prostate Cancer
Bladder Cancer
Parotid Gland Cancer
Cancer
Small Cell Lung Cancer
Skin Cancer
Testicular cancer
Non-Small Cell Lung Cancer
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
This trial is testing a drug called sacituzumab govitecan-hziy, which targets and kills cancer cells. It focuses on patients with advanced triple-negative breast cancer who have limited treatment options. The drug works by attaching to cancer cells and releasing a substance that kills them. Sacituzumab govitecan-hziy is an FDA-approved treatment for metastatic triple-negative breast cancer, especially for patients who have already tried other treatments.
Recruiting4 awards Phase 3
Gedatolisib + Fulvestrant +/- Palbociclib
for Advanced Breast Cancer
This trial is testing a combination of drugs to treat advanced breast cancer that has not responded to other treatments. The drugs work by blocking growth signals, breaking down estrogen receptors, and stopping cell division. Tamoxifen is a commonly used drug that blocks estrogen receptors to treat breast cancer, but resistance to it often develops.
Recruiting2 awards Phase 311 criteria
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Rush University Medical Center?
Where is Rush University Medical Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does Rush University Medical Center accept?
What awards or recognition has Rush University Medical Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.